Article
Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells
4 May 2019
Abstract excerpt
Drug resistance is a serious concern in a clinical setting jeopardizing treatment for both infectious agents and cancers alike. The wide-spread emergence of multi-drug resistant (MDR) phenotypes from bacteria to cancerous cells necessitates the need to target resistance mechanisms and prevent the emergence of resistant mutants. Drug efflux seems to be one of the preferred approaches embraced by both microbial and...
Topics
Join the communities discussing this publication.